Large Intragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated Spastic Paraparesis, SPG23.

[1]  Liangdan Sun,et al.  Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci , 2016, Front. Genet..

[2]  S. Mandal,et al.  Vitiligo with spastic paraparesis: A rare neurocutaneous syndrome , 2009, Journal of Pediatric Neurology.

[3]  S. Kirker,et al.  Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing , 2014, Journal of Neurology.

[4]  Rui Chen,et al.  DSTYK kinase domain ablation impaired the mice capabilities of learning and memory in water maze test. , 2014, International journal of clinical and experimental pathology.

[5]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[6]  R. Spritz.  Modern vitiligo genetics sheds new light on an ancient disease , 2013, The Journal of dermatology.

[7]  R. Ravazzolo,et al.  Mutations in DSTYK and dominant urinary tract malformations. , 2013, The New England journal of medicine.

[8]  Chunquan Li,et al.  CNVD: Text mining‐based copy number variation in disease database , 2012, Human mutation.

[9]  Nicholas W. Wood,et al.  A robust model for read count data in exome sequencing experiments and implications for copy number variant calling , 2012, Bioinform..

[10]  U. Suter,et al.  Schwann Cell Precursors from Nerve Innervation Are a Cellular Origin of Melanocytes in Skin , 2009, Cell.

[11]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[12]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 , 2005, Cell Death and Differentiation.

[13]  C. Morris,et al.  Double complex mutations involving F8 and FUNDC2 caused by distinct break‐induced replication , 2007, Human mutation.

[14]  Jan-Fang Cheng,et al.  Dusty protein kinases: primary structure, gene evolution, tissue specific expression and unique features of the catalytic domain. , 2006, Biochimica et biophysica acta.

[15]  P. Stenson,et al.  Intrachromosomal serial replication slippage in trans gives rise to diverse genomic rearrangements involving inversions , 2005, Human mutation.

[16]  J. Tschopp,et al.  The RIP kinases: crucial integrators of cellular stress. , 2005, Trends in biochemical sciences.

[17]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death , 2005, Cell Death and Differentiation.

[18]  Z. Zhai,et al.  RIP5 is a RIP-homologous inducer of cell death. , 2004, Biochemical and biophysical research communications.

[19]  S. Blumen,et al.  A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24‐q32 , 2003, Annals of neurology.

[20]  J. Bamforth.  Vitiligo-spasticity syndrome: new case. , 2003, Clinical dysmorphology.

[21]  David Botstein,et al.  SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data , 2003, Nucleic Acids Res..

[22]  D. Bredesen,et al.  An alternative, nonapoptotic form of programmed cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Metzker,et al.  Spastic paraparesis, mental retardation, and cutaneous pigmentation disorder. A new syndrome. , 1985, American journal of diseases of children.

[24]  Y. Hiss,et al.  Progressive spastic paraparesis, vitiligo, premature graying, and distinct facial appearance: a new genetic syndrome in 3 sibs. , 1981, American journal of medical genetics.

[25]  W. Mcdonald,et al.  Disordered pigmentation, spastic paraparesis and peripheral neuropathy in three siblings: a new neurocutaneous syndrome. , 1980, Journal of neurology, neurosurgery, and psychiatry.